Skip to content
WorldBrand.AI

JD Health

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2022

    JD Pharmacy Named for Price Gouging During Pandemic

    After China adjusted its epidemic prevention policy in December 2022, demand for fever-reducing drugs surged, and JD Pharmacy and multiple pharmacy outlets of drug companies were named by market regulators for price gouging. According to local penalty information, a Qingdao JD Pharmacy outlet was also fined for selling drugs suspected of counterfeit patents and for non-compliant labels on disinfection products. Named and rectified.

    Source